Viewing Study NCT01680159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:42 PM
Ignite Modification Date: 2026-02-02 @ 8:55 AM
Study NCT ID: NCT01680159
Status: COMPLETED
Last Update Posted: 2017-03-13
First Post: 2012-08-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
Sponsor: Tanabe Pharma Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Plaque Psoriasis View
None Psoriatic Arthritis View
None Pustular Psoriasis (Excluding a Localized) View
None Psoriatic Erythroderma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Infliximab View
None REMICADE View
None TA-650 View
None psoriasis View